Recent advances in our understanding of the pathogenesis of inflammatory bowel disease
(IBD) have highlighted the complex interplay between the genome, the epigenome, and the …

The function of non-coding RNAs (ncRNAs) in the pathogenesis and development of cancer
is indisputable. Molecular mechanisms underlying carcinogenesis involve the aberrant …

Aims This study aimed to conduct a bibliometric analysis of the relevant literature on the
diagnosis of inflammatory bowel disease (IBD), and show its current status, hot spots, and …

In recent decades, the development of new drugs has become increasingly expensive and
inefficient, and the molecular mechanisms of most pharmaceuticals remain poorly …

Introduction Ulcerative colitis (UC) is a chronic illness requiring lifelong management that
could be enhanced by personalizing care using biomarkers. Areas covered The main …

MicroRNAs (miRNAs) are a group of non-coding RNAs that play a critical role in regulating
epigenetic mechanisms in inflammation-related diseases. Inflammatory bowel diseases …

Crohn's disease (CD) is an inflammatory bowel disease (IBD) with complex clinical
manifestations such as chronic diarrhea, weight loss and hematochezia. Despite the …

Novel reliable biomarkers of inflammatory bowel disease (IBD) are clinically imperative due
to potential limitations of endoscopic techniques. MicroRNAs (miRNAs) have emerged as …

Background A significant body of research strengthens the starring role of long non-coding
RNAs (lncRNAs) and microRNAs (miRNAs) in the pathogenesis of inflammatory bowel …

Blood-based biomarkers that reliably indicate disease activity in the intestinal tract are an
important unmet need in the management of patients with IBD. Extracellular vesicles (EVs) …